Check your EU AI Act status

    Get a free risk tier assessment and personalized gap checklist in 5 minutes.

    Take the Assessment
    Implementation Guide: Healthcare

    Generative AI Governance for Clinical Policies and Order Sets

    Treat AI-drafted clinical content as a governed workflow, not a standalone model decision. Define permitted use cases and risk tiers, limit the AI tooling to approved sources and actions, assign named clinical owners to review and approve each draft, enforce those rules at runtime, and keep records that connect every draft to its model, prompt, source material, data access, reviewers, and approval decisions.

    Why existing clinical content governance needs an AI layer

    Clinical policies and order sets are already governed through committees and named clinical reviewers. When generative AI drafts that content, the same governance applies, and it needs controls that cover the AI tooling itself. The first step is to map the clinical content lifecycle to AI controls, so that each stage of drafting, review, and approval has a defined rule and a defined owner.

    Governed workflow for AI-drafted clinical content

    Five stages of the workflow, from scope to evidence.
    StageControl
    1. ScopePermitted use cases and risk tiers
    2. AccessApproved sources and least-privilege agent permissions
    3. ReviewNamed clinical owners and committee approval
    4. EnforcementRuntime policy on tool calls and data access
    5. EvidenceAudit records linking drafts to inputs and decisions

    Define permitted use cases, risk tiers, and source boundaries

    Start by defining which use cases are permitted and assigning each a risk tier. Controls can then vary by tier, and drafts can be routed to the right clinical owners for human review.

    Next, limit the AI tooling to approved sources and actions. Agent identities and permissions should be restricted to approved evidence repositories and internal systems, following a least-privilege approach.

    Assign named clinical owners for review and approval

    Every draft needs a named clinical owner to review and approve it. Reviewer sign-off and committee approval should be tied to the draft and its change history, so that responsibility for the final content is clear.

    Enforce policy at runtime, not only in documentation

    Written policy alone does not control what an AI tool does while drafting. Enforce the rules at runtime, so that tool calls and data access are allowed or blocked by policy, with every decision logged.

    Keep audit records that make a draft traceable

    Keep records that connect every draft to the following:

    • The model used
    • The prompt
    • The source material
    • The data accessed
    • The reviewers
    • The approval decisions

    Evaluation criteria for supporting tooling

    Use these questions to assess whether tooling can support the controls described above.

    • Does it record the model version, prompt, source documents, and data access behind each draft?
    • Can agent identities and permissions be limited to approved evidence repositories and internal systems?
    • Can tool calls be allowed or blocked by policy at runtime, with every decision logged?
    • Can draft records be linked to reviewer sign-off, committee approval, and change history?
    • Can controls vary by risk tier and route drafts to the right clinical owners for human review?

    Put runtime controls behind your clinical content governance

    Discuss how agent identity, scoped permissions, tool approval workflows, and audit logging can support your AI-assisted authoring process.

    Request a Demo